Zoonotic Disease Treatment Market: Analysis of Future Demand and Leading Key Players by 2030

The Business Research Company

The Business Research Company’s Zoonotic Disease Treatment Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, May 6, 2026 /EINPresswire.com/ -- The treatment of diseases transmitted from animals to humans, known as zoonotic diseases, has become an increasingly important area within healthcare. As the interaction between humans and animals grows and global food demands rise, the need for effective medical solutions to address these infections is more critical than ever. Let’s delve into the forecast, key growth factors, and regional dynamics shaping the zoonotic disease treatment market over the coming years.

Expected Market Trajectory for Zoonotic Disease Treatment Between 2025 and 2030
The zoonotic disease treatment market has witnessed substantial growth in recent years. Analysts predict the market will expand from $42.51 billion in 2025 to $45.48 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.0%. This rise during the past period has been driven by frequent transmission outbreaks of zoonotic diseases, insufficient surveillance of illnesses in animal populations, heavy reliance on traditional antibiotics, fragmented coordination between animal and human health systems, and increased close contact between humans and animals.

Download a free sample of the zoonotic disease treatment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Apr_PR

Looking ahead, the market is set to maintain strong momentum, reaching $57.77 billion by 2030 with a CAGR of 6.2%. Key contributors to this growth include improved diagnostic tools and therapeutic options for zoonotic diseases, wider implementation of integrated One Health strategies, enhanced government funding aimed at controlling zoonotic outbreaks, expanded vaccination programs for animals, and the scaling up of global disease monitoring initiatives. Prominent trends shaping the market involve a rise in zoonotic outbreaks, a greater emphasis on preventive care and prophylactic treatments, escalating demand for broad-spectrum anti-infective drugs, growth in combined human-animal health programs, and a focus on early detection coupled with swift treatment starts.

Understanding the Scope of Zoonotic Disease Treatment
Zoonotic disease treatment encompasses various medical interventions targeting infections that spread between animals and humans. This field combines the use of medications, vaccinations, hygiene protocols, and infection control measures designed to reduce transmission risk and lessen the impact of these diseases on both animal and human populations. The approach integrates clinical care with preventative strategies to manage these illnesses effectively.

View the full zoonotic disease treatment market report:
https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Apr_PR

Fundamental Market Drivers Behind the Growth of Zoonotic Disease Treatments
The rising global appetite for animal proteins is a primary catalyst stimulating the zoonotic disease treatment market. Animal proteins, sourced from meat, dairy, eggs, and fish, provide all essential amino acids vital for human health. Factors such as population growth, urbanization, increased income levels, and heightened awareness of the nutritional benefits of animal-based foods have collectively driven this demand. The zoonotic disease treatment sector plays a crucial role in managing illnesses linked to animal protein production by guiding understanding of transmission pathways, supporting the development of effective therapies, and promoting preventive measures to safeguard public health. For instance, in March 2025, data from the Australian Bureau of Statistics revealed a 2.3% increase in per capita consumption of meat and poultry compared to the previous year, reflecting a marked rise in animal protein intake nationally. This growing consumption pattern underscores the expanding market for zoonotic disease treatments.

Impact of Expanding Livestock Production on the Zoonotic Disease Treatment Market
The increase in global livestock production is another significant force driving the market forward. Livestock production involves the systematic breeding, raising, and management of domesticated animals to produce food, fiber, labor, and other goods for human use. The surge in livestock farming results from population growth and shifting dietary preferences favoring animal-based products. This sector plays a crucial role in zoonotic disease treatment efforts by acting as a key point for disease surveillance, research, and health management in animals. It facilitates early pathogen detection, vaccine and therapeutic development, and biosecurity practices aimed at minimizing disease transmission between animals and humans, while supporting integrated One Health responses. For example, official statistics from a UK government agency in July 2025 indicated that the total value of livestock output in the UK reached £20.1 billion ($23.69 billion) in 2024, up £1.1 billion ($1.30 billion) or 5.6% from the previous year. This growth was primarily driven by price increases and greater production in eggs, beef, and milk sectors. Such developments highlight how rising livestock production fuels expansion within the zoonotic disease treatment market.

Regional Leaders and Growth Prospects in the Zoonotic Disease Treatment Sector
In 2025, North America represented the largest share of the zoonotic disease treatment market. Meanwhile, the Asia-Pacific region is expected to experience the fastest growth throughout the forecast period. The market analysis encompasses regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global outlook on market trends and opportunities.

Browse Through More Reports Similar to the Global Zoonotic Disease Treatment Market 2026, By The Business Research Company
Monkey Pox Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Animal Medicine Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.